Tills vidare finns de senaste nyheterna att läsa på vår IR-sida.
[read_newsfeed_js items_to_display=70 style=nice_table current_language=sv]
Tills vidare finns de senaste nyheterna att läsa på vår IR-sida.
[read_newsfeed_js items_to_display=70 style=nice_table current_language=sv]
Respiratorius AB (publ) develops candidate drugs with the goal of launching drugs to treat aggressive lymphoma (cancer).
Respiratorius AB
Medicon Village
Scheeletorget 1, 223 81 Lund, Sweden
info@respiratorius.com
+46 70 922 41 40
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Leave a Reply
Want to join the discussion?Feel free to contribute!